Market Research Logo

Novavax, Inc. - Strategy and SWOT Report

Novavax, Inc. - Strategy and SWOT Report,

is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Novavax, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
  • Intelligence on Novavax, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Novavax, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Novavax (or 'the company') is a biopharmaceutical company focused on developing recombinant vaccines. The company's technology platform is based on recombinant nanoparticle vaccine technology that includes virus-like particles (VLPs) and protein nanoparticles. Novavax operates in the US where it is headquartered in Rockville, Maryland. It employed 308 people as on February 23, 2015.

Reasons to Purchase:
  • Gain understanding of Novavax, Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Novavax, Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Novavax, Inc.’s business structure, strategy and prospects


Company Snapshot
Novavax, Inc.: Company Overview
Novavax, Inc.: Overview and Key Facts
Novavax, Inc.: Overview
Novavax, Inc.: Key Facts
Novavax, Inc.: Key Employees
Novavax, Inc.: Key Employee Biographies
Novavax, Inc.: Major Products and Services
Novavax, Inc.: Company History
Novavax, Inc.: Management Statement
Novavax, Inc.: Locations and Subsidiaries
Novavax, Inc.: Key Competitors
Novavax, Inc.: Company Analysis
Novavax, Inc.: Business Description
Novavax, Inc.: SWOT Analysis
Novavax, Inc.: SWOT Overview
Novavax, Inc.: Strengths
Novavax, Inc.: Weaknesses
Novavax, Inc.: Opportunities
Novavax, Inc.: Threats
Novavax, Inc.: Corporate Financial Deals Activity
Novavax, Inc.: Financial Deals Overview
Novavax, Inc.: Targets and Partners
Novavax, Inc.: Top Deals 2011 - 2015YTD*
Novavax, Inc.: Advisors
Novavax, Inc.: Top Legal Advisors
Novavax, Inc.: Top Financial Advisors
Novavax, Inc.: Mergers and Acquisitions
Novavax, Inc.: Capital Raising
Novavax, Inc.: Partnership
Novavax, Inc.: Private Equity and Ownership
Novavax, Inc.: Recent Developments
Novavax, Inc.: News and Events Summary
Novavax, Inc.: Corporate Governance
Novavax, Inc.: Financial Performance
Novavax, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: Novavax, Inc.: Key Facts
Table 2: Novavax, Inc.: Key Employees
Table 4: Novavax, Inc.: Key Competitors
Table 5: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Table 7: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Novavax, Inc.: Targets and Partners
Table 9: Novavax, Inc.: Top Deals 2011 - 2015YTD*
Table 10: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Novavax, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
Table 13: Novavax, Inc.: M&A Activity by Geography (2011 - YTD*2015)
Table 14: Novavax, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
Table 15: Novavax, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
Table 16: Novavax, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
Table 17: Novavax, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
Table 18: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
Table 19: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
Table 20: Novavax, Inc.: News and Events Summary
Table 21: Novavax, Inc.: Corporate Governance
Table 22: Novavax, Inc.: Financial Performance
Table 23: Novavax, Inc.: Research & Development
List of Figures
Figure 1: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Novavax, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Figure 3: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Novavax, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
Figure 5: Novavax, Inc.: M&A Activity by Geography (2011 - YTD*2015)
Figure 6: Novavax, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
Figure 7: Novavax, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
Figure 8: Novavax, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
Figure 9: Novavax, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
Figure 10: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
Figure 11: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report